Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04383782 · ClinicalTrials.gov registry record · NA
Examining Outcome Expectancies and Behavioral Reinforcers Among Young Adult Smokers
A NA study of Smoking Cessation, sponsored by American University.
- Completed
- Registry status
- NA
- Development phase
- 159
- Enrollment target
- 1
- Study location
NCT04383782: Completed NA study of Smoking Cessation, sponsored by American University.
NCT04383782 is a NA study of Smoking Cessation that has completed, run by American University. The registered enrollment target is 159 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04383782, a NA study of Smoking Cessation, has completed, sponsored by American University.
- COMPLETED
- Registry status
- NA
- Development phase
- 159 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic cigarette smoking habits often begin in adolescence or early adulthood. 98% of cigarette smokers try their first cigarette before the age of 26. Thus, young adult smokers represent an important target for early smoking cessation intervention. This study tests two interventions designed to increase motivation to quit and decrease smoking behavior. These interventions include: an expectancy challenge approach, which aims to increase negative beliefs about the consequences of smoking; and a behavioral economics approach, which encourages participants to substitute non-smoking behaviors that may still provide reinforcement similar to reinforcement derived from smoking a cigarette.
Primary Outcome
yes/no, whether or not the participant made a 24-hour (or longer) quit attempt between the date of the main experiment and the date of the 4-week follow-up assessment.
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Expectancy Challenge
- BEHAVIORAL Expectancy Challenge + Behavioral Activation
Study Locations (1)
District of Columbia
- American University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2020-05-22 |
| Est. Completion | 2021-01-04 |
| Phase | NA |
What the finished NCT04383782 record still lists
NCT04383782 is an interventional study that assigns participants to a tested intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT04383782 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04383782 about?
NCT04383782 is a clinical study titled "Examining Outcome Expectancies and Behavioral Reinforcers Among Young Adult Smokers". Chronic cigarette smoking habits often begin in adolescence or early adulthood. 98% of cigarette smokers try their first cigarette before the age of 26. Thus, young adult smokers represent an important target for early smoking cessation intervention. This study tests two interventions designed to in...
What is the current status of trial NCT04383782?
This trial is currently completed. It is a NA study. The enrollment target is 159 participants. The study started on 2020-05-22. Estimated completion is 2021-01-04.
What conditions does trial NCT04383782 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT04383782?
The interventions under investigation include: Control (BEHAVIORAL), Expectancy Challenge (BEHAVIORAL), Expectancy Challenge + Behavioral Activation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04383782?
This trial is sponsored by American University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04383782 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04383782's enrollment target sits among peer trials
159 100th of 188 higher than 89 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI